Skip to content
1887

Journal of Medical Microbiology logo Journal of Medical Microbiology

Volume 73, Issue 7

A high-throughput assay identifies molecules with antimicrobial activity against persister cells Open Access

Abstract

Persister cells are transiently non-growing antibiotic-tolerant bacteria that cause infection relapse, and there is no effective antibiotic therapy to tackle these infections.

High-throughput assays in drug discovery are biased towards detecting drugs that inhibit bacterial growth rather than killing non-growing bacteria. A new and simple assay to discover such drugs is needed.

This study aims to develop a simple and high-throughput assay to identify compounds with antimicrobial activity against persister cells and use it to identify molecular motifs with such activity.

We quantified persister cells by enumeration of colony forming units after 24 h ciprofloxacin treatment. We first quantified how the cell concentration, antibiotic concentration, growth phase and presence/absence of nutrients during antibiotic exposure affected the fraction of persister cells in a population. After optimizing these parameters, we screened the antimicrobial activity of compound fragments to identify molecular structures that have activity against persister cells.

Exponential- and stationary-phase cultures transferred to nutrient-rich media displayed a bi-phasic time-kill curve and contained 0.001–0.07% persister cells. A short rifampicin treatment resulted in 100% persister cells for 7 h, after which cells resumed activity and became susceptible. Stationary-phase cultures displayed a low but constant death rate but ultimately resulted in similarly low survival rates as the exponential-phase cultures after 24 h ciprofloxacin treatment. The persister phenotype was only maintained in most of the population for 24 h if cells were transferred to a carbon-free minimal medium before exposure to ciprofloxacin. Keeping cells starved enabled the generation of high concentrations of cells that tolerate 50× MIC ciprofloxacin, and we used this protocol for rapid screening for biocidal antibiotics. We identified seven compounds from four structural clusters with activity against antibiotic-tolerant . Two compounds were moderately cytotoxic, and the rest were highly cytotoxic.

Transferring a stationary-phase culture to a carbon-free minimal medium for antimicrobial testing is a simple strategy for high-throughput screening for new antibiotics that kill persister cells. We identified molecule fragments with such activity, but further screening is needed to identify motifs with lower general cytotoxicity.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): drug development , persister cells and Staphylococcus aureus
Funding
This study was supported by the:
  • Novo Nordisk Fonden (Award NNF19OC0058357)
    • Principle Award Recipient: RikkeLouise Meyer
© 2024 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001856
2024-07-12
2025-05-25
Loading full text...

Full text loading...

/deliver/fulltext/jmm/73/7/jmm001856.html?itemId=/content/journal/jmm/10.1099/jmm.0.001856&mimeType=html&fmt=ahah

References

  1. Hobby GL, Meyer K, Chaffee E. Observations on the mechanism of action of penicillin. Proc Soc Exp Biol Med 1942; 50:281–285 [View Article]
     [Google Scholar]
  2. Bigger JW. The bactericidal action of penicillin on Staphylococcus pyogenes. Ir J Med Sci 1944; 19:585–595 [View Article]
     [Google Scholar]
  3. Balaban NQ, Helaine S, Lewis K, Ackermann M, Aldridge B et al. Definitions and guidelines for research on antibiotic persistence. Nat Rev Microbiol 2019; 17:441–448 [View Article] [PubMed]
     [Google Scholar]
  4. Audrain B, Ferrières L, Zairi A, Soubigou G, Dobson C et al. Induction of the Cpx envelope stress pathway contributes to Escherichia coli tolerance to antimicrobial peptides. Appl Environ Microbiol 2013; 79:7770–7779 [View Article] [PubMed]
     [Google Scholar]
  5. Gutierrez A, Jain S, Bhargava P, Hamblin M, Lobritz MA et al. Understanding and sensitizing density-dependent persistence to quinolone antibiotics. Mol Cell 2017; 68:1147–1154 [View Article] [PubMed]
     [Google Scholar]
  6. Peyrusson F, Nguyen TK, Najdovski T, Van Bambeke F. Host cell oxidative stress induces dormant Staphylococcus aureus persisters. Microbiol Spectr 2022; 10:e0231321 [View Article] [PubMed]
     [Google Scholar]
  7. Hong SH, Wang X, O’Connor HF, Benedik MJ, Wood TK. Bacterial persistence increases as environmental fitness decreases. Microb Biotechnol 2012; 5:509–522 [View Article] [PubMed]
     [Google Scholar]
  8. Peyrusson F, Varet H, Nguyen TK, Legendre R, Sismeiro O et al. Intracellular Staphylococcus aureus persisters upon antibiotic exposure. Nat Commun 2020; 11:2200 [View Article] [PubMed]
     [Google Scholar]
  9. Stokes JM, Lopatkin AJ, Lobritz MA, Collins JJ. Bacterial metabolism and antibiotic efficacy. Cell Metab 2019; 30:251–259 [View Article] [PubMed]
     [Google Scholar]
  10. Lobritz MA, Belenky P, Porter CBM, Gutierrez A, Yang JH et al. Antibiotic efficacy is linked to bacterial cellular respiration. Proc Natl Acad Sci U S A 2015; 112:8173–8180 [View Article] [PubMed]
     [Google Scholar]
  11. Yang JH, Bening SC, Collins JJ. Antibiotic efficacy--context matters. Curr Opin Microbiol 2017; 39:73–80 [View Article] [PubMed]
     [Google Scholar]
  12. Liu S, Huang Y, Jensen S, Laman P, Kramer G et al. Molecular physiological characterization of the dynamics of persister formation in Staphylococcus aureus. Antimicrob Agents Chemother 2024; 68:e0085023 [View Article] [PubMed]
     [Google Scholar]
  13. Conlon BP. Staphylococcus aureus chronic and relapsing infections: evidence of a role for persister cells: an investigation of persister cells, their formation and their role in S. aureus disease. Bio Essays 2014; 36:991–996 [View Article] [PubMed]
     [Google Scholar]
  14. Libraty DH, Patkar C, Torres B. Staphylococcus aureus reactivation osteomyelitis after 75 years. N Engl J Med 2012; 366:481–482 [View Article] [PubMed]
     [Google Scholar]
  15. Hindler JF, Munro S. Antimicrobial susceptibility testing. In Hindler JF, Munro S. eds Encyclopedia of Microbiology Wiley: pp 166–175
     [Google Scholar]
  16. Rajamuthiah R, Fuchs BB, Conery AL, Kim W, Jayamani E et al. Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus. PLoS One 2015; 10:e0124595 [View Article] [PubMed]
     [Google Scholar]
  17. Sondergaard TE, Fredborg M, Oppenhagen Christensen A-M, Damsgaard SK, Kramer NF et al. Fast screening of antibacterial compounds from Fusaria. Toxins 2016; 8:355 [View Article] [PubMed]
     [Google Scholar]
  18. Wang Y, Bojer MS, George SE, Wang Z, Jensen PR et al. Inactivation of TCA cycle enhances Staphylococcus aureus persister cell formation in stationary phase. Sci Rep 2018; 8:1–13 [View Article] [PubMed]
     [Google Scholar]
  19. Conlon BP, Rowe SE, Gandt AB, Nuxoll AS, Donegan NP et al. Persister formation in Staphylococcus aureus is associated with ATP depletion. Nat Microbiol 2016; 1:16051 [View Article] [PubMed]
     [Google Scholar]
  20. Kwan BW, Valenta JA, Benedik MJ, Wood TK. Arrested protein synthesis increases persister-like cell formation. Antimicrob Agents Chemother 2013; 57:1468–1473 [View Article] [PubMed]
     [Google Scholar]
  21. Song S, Wood TK. Are we really studying persister cells?. Environ Microbiol Rep 2021; 13:3–7 [View Article] [PubMed]
     [Google Scholar]
  22. Harms A, Fino C, Sørensen MA, Semsey S, Gerdes K. Prophages and growth dynamics confound experimental results with antibiotic-tolerant persister cells. mBio 2017; 8:e01964-17 [View Article] [PubMed]
     [Google Scholar]
  23. Şimşek E, Kim M. Power-law tail in lag time distribution underlies bacterial persistence. Proc Natl Acad Sci U S A 2019; 116:17635–17640 [View Article] [PubMed]
     [Google Scholar]
  24. Kim J, Yamasaki R, Song S, Zhang W, Wood TK. Single cell observations show persister cells wake based on ribosome content. Environ Microbiol 2018; 20:2085–2098 [View Article] [PubMed]
     [Google Scholar]
  25. Kim JS, Chowdhury N, Yamasaki R, Wood TK. Viable but non-culturable and persistence describe the same bacterial stress state. Environ Microbiol 2018; 20:2038–2048 [View Article] [PubMed]
     [Google Scholar]
  26. Oliveira WF, Silva PMS, Silva RCS, Silva GMM, Machado G et al. Staphylococcus aureus and Staphylococcus epidermidis infections on implants. J Hosp Infect 2018; 98:111–117 [View Article] [PubMed]
     [Google Scholar]
  27. Grassi L, Di Luca M, Maisetta G, Rinaldi AC, Esin S et al. Generation of persister cells of Pseudomonas aeruginosa and Staphylococcus aureus by chemical treatment and evaluation of their susceptibility to membrane-targeting agents. Front Microbiol 2017; 8:1917 [View Article] [PubMed]
     [Google Scholar]
  28. Reed P, Atilano ML, Alves R, Hoiczyk E, Sher X et al. Staphylococcus aureus survives with a minimal peptidoglycan synthesis machine but sacrifices virulence and antibiotic resistance. PLoS Pathog 2015; 11:e1004891 [View Article] [PubMed]
     [Google Scholar]
  29. Kwan BW, Chowdhury N, Wood TK. Combatting bacterial infections by killing persister cells with mitomycin C. Environ Microbiol 2015; 17:4406–4414 [View Article] [PubMed]
     [Google Scholar]
  30. Udekwu KI, Parrish N, Ankomah P, Baquero F, Levin BR. Functional relationship between bacterial cell density and the efficacy of antibiotics. J Antimicrob Chemother 2009; 63:745–757 [View Article] [PubMed]
     [Google Scholar]
  31. Tan C, Smith RP, Srimani JK, Riccione KA, Prasada S et al. The inoculum effect and band-pass bacterial response to periodic antibiotic treatment. Mol Syst Biol 2012; 8:617 [View Article] [PubMed]
     [Google Scholar]
  32. Sandvik EL, Fazen CH, Henry TC, Mok WWK, Brynildsen MP. Non-monotonic survival of Staphylococcus aureus with respect to ciprofloxacin concentration arises from prophage-dependent killing of persisters. Pharmaceuticals 2015; 8:778–792 [View Article] [PubMed]
     [Google Scholar]
  33. Xu Y, Maltesen RG, Larsen LH, Schønheyder HC, Le VQ et al. In vivo gene expression in a Staphylococcus aureus prosthetic joint infection characterized by RNA sequencing and metabolomics: a pilot study. BMC Microbiol 2016; 16:80 [View Article] [PubMed]
     [Google Scholar]
  34. Song S, Wood TK. ppGpp ribosome dimerization model for bacterial persister formation and resuscitation. Biochem Biophys Res Commun 2020; 523:281–286 [View Article] [PubMed]
     [Google Scholar]
  35. Hobbs JK, Boraston AB. (p)ppGpp and the stringent response: an emerging threat to antibiotic therapy. ACS Infect Dis 2019; 5:1505–1517 [View Article] [PubMed]
     [Google Scholar]
  36. Fritsch VN, Loi VV, Busche T, Tung QN, Lill R et al. The alarmone (p)ppGpp confers tolerance to oxidative stress during the stationary phase by maintenance of redox and iron homeostasis in Staphylococcus aureus. Free Radic Biol Med 2020; 161:351–364 [View Article] [PubMed]
     [Google Scholar]
  37. Ranganathan N, Johnson R, Edwards AM. The general stress response of Staphylococcus aureus promotes tolerance of antibiotics and survival in whole human blood. Microbiology 2020; 166:1088–1094 [View Article] [PubMed]
     [Google Scholar]
  38. Maisonneuve E, Castro-Camargo M, Gerdes K. (p)ppGpp controls bacterial persistence by stochastic induction of toxin-antitoxin activity. Cell 2018; 172:1135 [View Article] [PubMed]
     [Google Scholar]
  39. Ueta M, Wada C, Daifuku T, Sako Y, Bessho Y et al. Conservation of two distinct types of 100S ribosome in bacteria. Genes Cells 2013; 18:554–574 [View Article] [PubMed]
     [Google Scholar]
  40. Kim JS, Wood TK. Persistent Persister Misperceptions. Front Microbiol 2016; 7:1–7 [View Article] [PubMed]
     [Google Scholar]
  41. Kim JS, Wood TK. Tolerant, growing cells from nutrient shifts are not persister Cells. Am Soc Microbiol 2017; 8:1–5 [View Article] [PubMed]
     [Google Scholar]
  42. Cruz-Muñiz MY, López-Jacome LE, Hernández-Durán M, Franco-Cendejas R, Licona-Limón P et al. Repurposing the anticancer drug mitomycin C for the treatment of persistent Acinetobacter baumannii infections. Int J Antimicrob Agents 2017; 49:88–92 [View Article] [PubMed]
     [Google Scholar]
  43. Niu H, Cui P, Shi W, Zhang S, Feng J et al. Identification of anti-persister activity against uropathogenic Escherichia coli from a clinical drug library. Antibiotics 2015; 4:179–187 [View Article] [PubMed]
     [Google Scholar]
  44. Kim W, Conery AL, Rajamuthiah R, Fuchs BB, Ausubel FM et al. Identification of an antimicrobial agent effective against methicillin-resistant Staphylococcus aureus persisters using a fluorescence-based screening strategy. PLoS One 2015; 10:1–15 [View Article] [PubMed]
     [Google Scholar]
  45. Kim W, Zhu W, Hendricks GL, Van Tyne D, Steele AD et al. A new class of synthetic retinoid antibiotics effective against bacterial persisters. Nature 2018; 556:103–107 [View Article] [PubMed]
     [Google Scholar]
  46. Allison KR, Brynildsen MP, Collins JJ. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 2011; 473:216–220 [View Article] [PubMed]
     [Google Scholar]
  47. Marques CNH, Morozov A, Planzos P, Zelaya HM. The fatty acid signaling molecule cis-2-decenoic acid increases metabolic activity and reverts persister cells to an antimicrobial-susceptible state. Appl Environ Microbiol 2014; 80:6976–6991 [View Article] [PubMed]
     [Google Scholar]
  48. Song S, Wood TK. Persister cells resuscitate via ribosome modification by 23S rRNA pseudouridine synthase RluD. Environ Microbiol 2020; 22:850–857 [View Article] [PubMed]
     [Google Scholar]
  49. Stokes JM, Yang K, Swanson K, Jin W, Cubillos-Ruiz A et al. A deep learning approach to antibiotic discovery. Cell 2020; 180:688–702 [View Article] [PubMed]
     [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001856
Loading
A high-throughput assay identifies molecules with antimicrobial activity against persister cells
J. Med. Microbiol. 73, 001856 (2024); https://doi.org/10.1099/jmm.0.001856
/content/journal/jmm/10.1099/jmm.0.001856
/content/journal/jmm/10.1099/jmm.0.001856
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error